Osteoarthritis Therapeutics Global Market Report 2025

Description

Osteoarthritis therapeutics encompass a range of medical treatments and interventions aimed at managing and alleviating the symptoms of osteoarthritis, a degenerative joint disease marked by the deterioration of cartilage and underlying bone. These treatments include medications, physical therapies, lifestyle changes, and, in some cases, surgical procedures. The main objectives of osteoarthritis therapeutics are to reduce pain, enhance joint function, and improve the quality of life for those affected by the condition.

Key drug types for osteoarthritis management include viscosupplementation agents, nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, corticosteroids, and others. Viscosupplementation agents are injected directly into the joint to provide lubrication and cushioning, which helps relieve pain and improve mobility. The condition can affect various joints, such as the knee, hip, and hand, and treatments can be administered through different routes, including parenteral, topical, and oral. Sales channels for these therapeutics include prescription and over-the-counter drugs, with end-users ranging from hospital pharmacies to retail pharmacies and other outlets.

The osteoarthritis therapeutics market research report is one of a series of new reports from The Business Research Company that provides osteoarthritis therapeutics market statistics, including osteoarthritis therapeutics industry global market size, regional shares, competitors with a osteoarthritis therapeutics market share, detailed osteoarthritis therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the osteoarthritis therapeutics industry. This osteoarthritis therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The osteoarthritis therapeutics market size has grown strongly in recent years. It will grow from $8.17 $ billion in 2024 to $8.87 $ billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to an aging population, advancements in drug delivery systems, increasing awareness and diagnosis, development of novel therapies, and rising obesity rates.

The osteoarthritis therapeutics market size is expected to see strong growth in the next few years. It will grow to $12.22 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising obesity rates, advancements in treatment modalities, increasing awareness and diagnosis, development of disease-modifying osteoarthritis drugs (DMOADs), and government and private funding for research. Major trends in the forecast period include increasing focus on personalized medicine, the emergence of regenerative therapies, the expansion of pain management options, government and regulatory support, and rising demand in emerging markets.

The increase in sports injuries is expected to drive the growth of the osteoarthritis therapeutics market in the future. A sports injury refers to any damage or harm sustained during athletic activities, ranging from mild to severe, and affecting various parts of the body. The rise in sports injuries is primarily due to growing participation in sports and the increasing intensity and competitiveness of these activities. Osteoarthritis therapeutics are used to manage pain, reduce inflammation, and improve joint function in athletes experiencing joint degeneration from such injuries. For example, in 2022, the National Safety Council, a US-based nonprofit organization focused on health and safety, reported a 12% increase in sports and recreational injuries. As a result, the rising number of sports injuries is fueling the growth of the osteoarthritis therapeutics market.

Leading companies in the osteoarthritis therapeutics market are concentrating on developing innovative solutions, such as advancements in tissue regeneration for osteoarthritis. Tissue regeneration in osteoarthritis involves repairing or replacing damaged cartilage and joint tissues to restore function and alleviate pain. For instance, in May 2023, the Advanced Research Projects Agency for Health (ARPA-H), a US-based government agency, launched the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program. This program aims to create cutting-edge injectable therapies that stimulate cartilage repair by utilizing biological pathways similar to those active during embryonic development. A key aspect of NITRO is its collaborative, multimodal approach among research teams and the use of advanced testing techniques, such as "joint-on-a-chip" platforms that replicate joint environments. This initiative seeks to develop regenerative solutions that address the underlying causes of osteoarthritis, offering more effective long-term treatments.

In April 2022, Juniper Biologics Pte Ltd, a pharmaceutical company based in Singapore, acquired the licensing rights for TG-C LD (TissueGene-C low dose) from Kolon Life Science for $600 million. This acquisition positions Juniper Biologics as a leader in cell-mediated gene therapies for knee osteoarthritis, addressing a significant unmet medical need affecting around 300 million patients in the Asia Pacific, Middle East, and Africa regions. Kolon Life Science Inc., based in South Korea, specializes in osteoarthritis therapeutics.

Major companies operating in the osteoarthritis therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Zimmer Biomet Holdings Inc., Horizon Therapeutics plc, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Galapagos NV, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Samumed LLC, Orthogen AG, Kolon Life Science Inc.

North America was the largest region in the osteoarthritis therapeutics market in 2023. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the osteoarthritis therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The osteoarthritis therapeutics market consists of revenues earned by entities by providing services such as exercises and therapies, diagnostic services, and pain management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The osteoarthritis therapeutics market also includes sales of pain relievers, corticosteroids, hyaluronic acid injections, and assistive devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Osteoarthritis Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on osteoarthritis therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for osteoarthritis therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The osteoarthritis therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) Drug Type: Viscosupplementation Agents; Nonsteroidal Anti-inflammatory Drugs; Analgesics; Corticosteroids; Other Drug Types
2) By Anatomy: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis; Other Anatomies
3) By Route Of Administration: Parenteral Route; Topical Route; Oral Route
4) By Sales Channel: Prescription Drugs; Over-the-Counter Drugs
5) By End-use: Hospital Pharmacies; Retail Pharmacies; Other End-uses
Subsegments:
1) Viscosupplementation Agents: Hyaluronic Acid Injections; Single-Injection Products; Multi-Injection Products
2) Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs; Topical NSAIDs; COX-2 Inhibitors
3) Analgesics: Opioid Analgesics; Non-Opioid Analgesics; Topical Analgesics
4) Corticosteroids: Injectable Corticosteroids; Oral Corticosteroids; Intra-Articular Corticosteroids
5) Other Drug Types: Disease-Modifying Osteoarthritis Drugs (DMOADs); Platelet-Rich Plasma Therapy; Stem Cell Therapy
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r32121

1. Executive Summary

2. Osteoarthritis Therapeutics Market Characteristics

3. Osteoarthritis Therapeutics Market Trends And Strategies

4. Osteoarthritis Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Osteoarthritis Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Osteoarthritis Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Osteoarthritis Therapeutics Market Growth Rate Analysis
5.4. Global Osteoarthritis Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Osteoarthritis Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Osteoarthritis Therapeutics Total Addressable Market (TAM)

6. Osteoarthritis Therapeutics Market Segmentation

6.1. Global Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Viscosupplementation Agents
Nonsteroidal Anti-inflammatory Drugs
Analgesics
Corticosteroids
Other Drug Types
6.2. Global Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Other Anatomies
6.3. Global Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parenteral Route
Topical Route
Oral Route
6.4. Global Osteoarthritis Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prescription Drugs
Over-the-Counter Drugs
6.5. Global Osteoarthritis Therapeutics Market, Segmentation By End-use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Other End-uses
6.6. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Viscosupplementation Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hyaluronic Acid Injections
Single-Injection Products
Multi-Injection Products
6.7. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Nonsteroidal Anti-inflammatory Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral NSAIDs
Topical NSAIDs
COX-2 Inhibitors
6.8. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Opioid Analgesics
Non-Opioid Analgesics
Topical Analgesics
6.9. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable Corticosteroids
Oral Corticosteroids
Intra-Articular Corticosteroids
6.10. Global Osteoarthritis Therapeutics Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disease-Modifying Osteoarthritis Drugs (DMOADs)
Platelet-Rich Plasma Therapy
Stem Cell Therapy

7. Osteoarthritis Therapeutics Market Regional And Country Analysis

7.1. Global Osteoarthritis Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Osteoarthritis Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Osteoarthritis Therapeutics Market

8.1. Asia-Pacific Osteoarthritis Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Osteoarthritis Therapeutics Market

9.1. China Osteoarthritis Therapeutics Market Overview
9.2. China Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Osteoarthritis Therapeutics Market

10.1. India Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Osteoarthritis Therapeutics Market

11.1. Japan Osteoarthritis Therapeutics Market Overview
11.2. Japan Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Osteoarthritis Therapeutics Market

12.1. Australia Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Osteoarthritis Therapeutics Market

13.1. Indonesia Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Osteoarthritis Therapeutics Market

14.1. South Korea Osteoarthritis Therapeutics Market Overview
14.2. South Korea Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Osteoarthritis Therapeutics Market

15.1. Western Europe Osteoarthritis Therapeutics Market Overview
15.2. Western Europe Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Osteoarthritis Therapeutics Market

16.1. UK Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Osteoarthritis Therapeutics Market

17.1. Germany Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Osteoarthritis Therapeutics Market

18.1. France Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Osteoarthritis Therapeutics Market

19.1. Italy Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Osteoarthritis Therapeutics Market

20.1. Spain Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Osteoarthritis Therapeutics Market

21.1. Eastern Europe Osteoarthritis Therapeutics Market Overview
21.2. Eastern Europe Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Osteoarthritis Therapeutics Market

22.1. Russia Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Osteoarthritis Therapeutics Market

23.1. North America Osteoarthritis Therapeutics Market Overview
23.2. North America Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Osteoarthritis Therapeutics Market

24.1. USA Osteoarthritis Therapeutics Market Overview
24.2. USA Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Osteoarthritis Therapeutics Market

25.1. Canada Osteoarthritis Therapeutics Market Overview
25.2. Canada Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Osteoarthritis Therapeutics Market

26.1. South America Osteoarthritis Therapeutics Market Overview
26.2. South America Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Osteoarthritis Therapeutics Market

27.1. Brazil Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Osteoarthritis Therapeutics Market

28.1. Middle East Osteoarthritis Therapeutics Market Overview
28.2. Middle East Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Osteoarthritis Therapeutics Market

29.1. Africa Osteoarthritis Therapeutics Market Overview
29.2. Africa Osteoarthritis Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Osteoarthritis Therapeutics Market, Segmentation By Anatomy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Osteoarthritis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Osteoarthritis Therapeutics Market Competitive Landscape And Company Profiles

30.1. Osteoarthritis Therapeutics Market Competitive Landscape
30.2. Osteoarthritis Therapeutics Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Osteoarthritis Therapeutics Market Other Major And Innovative Companies

31.1. Sanofi S.A.
31.2. Bristol-Myers Squibb Company
31.3. Novartis AG
31.4. GlaxoSmithKline plc
31.5. Medtronic plc
31.6. Eli Lilly and Company
31.7. Gilead Sciences Inc.
31.8. Teva Pharmaceutical Industries Ltd.
31.9. Regeneron Pharmaceuticals Inc.
31.10. Daiichi Sankyo Company Limited
31.11. Zimmer Biomet Holdings Inc.
31.12. Horizon Therapeutics plc
31.13. Taisho Pharmaceutical Co. Ltd.
31.14. Ferring Pharmaceuticals
31.15. Galapagos NV

32. Global Osteoarthritis Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Osteoarthritis Therapeutics Market

34. Recent Developments In The Osteoarthritis Therapeutics Market

35. Osteoarthritis Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Osteoarthritis Therapeutics Market In 2029 - Countries Offering Most New Opportunities
35.2 Osteoarthritis Therapeutics Market In 2029 - Segments Offering Most New Opportunities
35.3 Osteoarthritis Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer